Wired Health will return to London for its seventh year on Wednesday 25th March 2020, welcoming global leaders in the health, pharmaceutical, patient care and digital health sectors.
The event is designed for executives seeking to engage with transformational technologies challenging the health industry, from neuroscience to treating cancer and delaying ageing, to the use of AI in health – with a focus on the innovations that are rapidly changing medicine and patient care. Delegates attending Wired Health will have the opportunity to network with individuals from the sector, including physicians, senior healthcare executives, innovators and investors, disruptors and incumbents.
Wired has announced the first nine speakers:
Robert Hariri, founder, chairman and CEO, Celularity
Hariri is the former CEO of Celgene and co-founder of Human Longevity. His latest venture is Celularity, has raised $250 million to develop stem cell technology to treat cancer and delay ageing. Hariri is an accomplished surgeon, biomedical scientist, jet engineer and serial entrepreneur.
Mei Mei Hu, co-founder and CEO, United Neuroscience
Hu is developing a vaccine for Alzheimer's. Her company's goal is to democratise brain health by pioneering a new class of medicine called endobody vaccines, which are fully synthetic and train the body to safely and efficiently treat and prevent neurological disease. In 2019, Hu was honoured by TIME Magazine in their "100 Next List," and by Fortune Magazine as one of their "40 Under 40" innovators.
Heidi Larson, professor of anthropology, risk and decision science; director, The Vaccine Confidence Project Dept. Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine
Larson is the director of the WHO’s Vaccine Confidence Project, an initiative tackling the anti-vax movement. Larson headed UNICEF’s strategy for the introduction of new vaccines and is the Principle Investigator of the project ensuring deployment, acceptance and compliance of an Ebola vaccine trial in Sierra Leone.
Indra Joshi, director of AI, NHSX
Joshi’s experience stretches across policy, digital health, national project strategy and implementation and is a Founding Member of One HealthTech – which campaigns for the need and importance of better inclusion in health technology.
Samuel Tisherman, professor, Department of Surgery and the Program in Trauma, University of Maryland School of Medicine; director, Center for Critical Care and Trauma Education, R Adams Cowley Shock Trauma Center, University of Maryland
Tisherman is working to save patients dying from trauma by placing them in suspended animation. He is conducting a clinical trial of this Emergency Preservation and Resuscitation, which uses hypothermia to "buy time" for resuscitative surgery.
Rachel Clarke, palliative care physician for the National Health Service, former journalist, activist and author
Clarke is the bestselling author of Your Life in My Hands, a book about her experiences as a doctor for the NHS. Her new book, Dear Life, is about palliative care and dealing with her father's terminal cancer diagnosis – exploring love, loss, grief, dying and what really matters at the end of life.
Angela Saini, science journalist, broadcaster and author
Saini is an award-winning British science journalist and broadcaster. She regularly presents radio and television programmes on the BBC, and her writing has appeared in New Scientist, the Guardian, The Sunday Times, and WIRED.
Maja Pantic, professor of affective & Behavioural Computing, Imperial College London and Research Director, Samsung AI Centre Cambridge
Pantic is one of the world's leading experts in the research on machine understanding of human behaviour including vision-based detection, tracking, and analysis of human behavioural cues like facial expressions and body gestures, and multimodal analysis of human behaviours like laughter, social signals, and affective states.
Godfrey Nazareth, president and CEO, X-Biomedical, Inc.
Nazareth is a biomedical engineer developing next-gen medical simulation systems and surgical visualisation technology, with collaborations including the US Military, American Heart Association, University of Pennsylvania and The Children's Hospital of Philadelphia. On a personal note, Nazareth proactively battles classical ALS; and uses a variety of self-built assistive devices to function, operate, and interact at the highest levels possible.
Additional names will be announced over the coming weeks.
